Green Organic Dutchman (TSX:TGOD) Stock Is Now Too Cheap to Ignore!

Green Organic Dutchman Holdings Ltd (TSX:TGOD) stock has been crushed alongside the cannabis bear market, but at current prices, the upside potential is too lucrative.

Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Green Organic Dutchman Holdings (TSX:TGOD) was once one of the best-performing cannabis stocks on the market. In its first 30 days of trading, shares nearly doubled. In 2018, it surpassed a $1 billion market cap.

This year, the story reversed course. Since March, Green Organic stock has shed 80% of its value. Of course, most other cannabis stocks have been hit hard, but Green Organic has led the industry lower.

Today, the company has a market cap of just $200 million. That’s despite expectations for $90 million in revenues next year, which would represent 800% year-over-year growth.

Green Organic shares are priced at the low end of the industry, with expectations near rock bottom. Even a small surprise to the upside could send shares soaring. We’ll talk about the risks in a moment, but it’s clear that this company could be the best-performing pot stock in 2020.

A dramatic fall

The momentum behind Green Organic’s initial rise was fueled by a key partnership with Aurora Cannabis. Late last year, nearly every pot producer was scrambling to secure valuable long-term allies. Green Organic’s deal with Aurora provided two key advantages.

First, Aurora would help Green Organic design and build its greenhouse infrastructure. Aurora had deep experience constructing grow facilities and even had a consulting arm dedicated for this purpose. Second, Aurora agreed to buy 20% of Green Organic’s pot production at wholesale prices. This secured early demand for Green Organic but also provided social validation to the rest of the market.

This year, however, Aurora cancelled the agreement. Instead, it would source its organic cannabis needs internally. Of course, Green Organic lost a large customer, but the deal termination also shed light on potential demand for organic cannabis. Many analysts believed Aurora simply didn’t need to purchase 20% of Green Organic’s output to satisfy the market’s demand for organic pot. If true, Green Organic may be overproducing by a factor of five or more.

Several cannabis markets in North America are already facing oversupply issues. In most cases, local prices have plummeted. If Aurora thought just 20% of Green Organic’s production was more than enough to meet market demand, Green Organic could face steep pricing pressure in the year to come.

Here’s the bet

Everyone knows the bad news. Green Organic has zero major customers lined up, while organic cannabis production could be massively oversupplied in 2020. There’s an argument, however, that all of the bad news has been more than priced in. Even if 2020 is a tough year, TGOD shareholders could still win given the overly depressed stock price.

Even if prices fall, organic output still fetches a 55% premium versus conventional cannabis. Additionally, surveys show that more than half of both medicinal and recreational pot users prefer organic strains. Set to become the largest organic producer in 2020, Green Organic will have a stranglehold on the market.

Importantly, two major grow facilities are set to come online in 2020, helping the company produce roughly 21,000 kilograms of pot next year. Management expects to be cash flow positive by the second quarter. That may eliminate any need for additional financing or dilution.

Additionally, the company is set to release a portfolio of value-add products this December, which should expand its reach while protecting pricing power. This portfolio includes new verticals like edibles, vapes, health aids, and beverages.

There are risks, but the upside is huge if Green Organic can execute in 2020. Shares trade at an 80% discount to its peers on both an EV/revenue and EV/EBITDA basis. The stock could more than double next year and still be another double away from the industry’s average valuation. That’s simply too cheap to ignore.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »